Global cancer statistics, 2012
Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet-Tieulent,Ahmedin Jemal +5 more
Reads0
Chats0
TLDR
A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.Abstract:
Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Over the years, the burden has shifted to less developed countries, which currently account for about 57% of cases and 65% of cancer deaths worldwide. Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and has surpassed breast cancer as the leading cause of cancer death among females in more developed countries; breast cancer remains the leading cause of cancer death among females in less developed countries. Other leading causes of cancer death in more developed countries include colorectal cancer among males and females and prostate cancer among males. In less developed countries, liver and stomach cancer among males and cervical cancer among females are also leading causes of cancer death. Although incidence rates for all cancers combined are nearly twice as high in more developed than in less developed countries in both males and females, mortality rates are only 8% to 15% higher in more developed countries. This disparity reflects regional differences in the mix of cancers, which is affected by risk factors and detection practices, and/or the availability of treatment. Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.read more
Citations
More filters
Journal ArticleDOI
Tumor Detection in Automated Breast Ultrasound Using 3-D CNN and Prioritized Candidate Aggregation
TL;DR: A fast and effective computer-aided detection system based on 3-D convolutional neural networks (CNNs) and prioritized candidate aggregation is proposed to accelerate reviewing of whole breast ultrasound slices and demonstrates promising results.
Journal ArticleDOI
Bio-inspired encapsulation and functionalization of iron oxide nanoparticles for biomedical applications
Samson O. Aisida,Paul A. Akpa,Ishaq Ahmad,Tingkai Zhao,Malik Maaza,Malik Maaza,Fabian I. Ezema +6 more
TL;DR: Recent advances in the development of FeO-NPs from fabrication to applications and the state-of-the-arts synthetic routes are discussed, with special attention to the biopolymer surface functionalization of FeNPs now and future perspective of drug delivery in oncologic disease therapy chiefly cancer cells.
Journal ArticleDOI
Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma
Wei-Feng Liu,Jie Hu,Kai-Qian Zhou,Feiyu Chen,Zheng Wang,Bo-Yi Liao,Zhi Dai,Ya Cao,Jia Fan,Jian Zhou +9 more
TL;DR: Exosomal miR-125b levels predicted the recurrence and survival of HCC patients with an area under the ROC curve of 0.739 and could serve as a promising prognostic marker for HCC.
Journal ArticleDOI
Dysbiosis of the Gut Microbiome in Lung Cancer.
He Zhuang,He Zhuang,Liang Cheng,Yao Wang,Yao Wang,Yu-Kun Zhang,Man-Fei Zhao,Gong-Da Liang,Meng-Chun Zhang,Meng-Chun Zhang,Yong-Guo Li,Jing-Bo Zhao,Yi-Na Gao,Yu-Jie Zhou,Yu-Jie Zhou,Shu-Lin Liu +15 more
TL;DR: The results provide the basic guidance for a systematic, multilayered assessment of the role of the gut microbiome in LC, which has a promising potential for early prevention and targeted intervention.
Journal ArticleDOI
The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α.
Ying Wang,Wanyuan Chen,Jiayan Lian,Haibo Zhang,Bo Yu,Minjun Zhang,Fangqiang Wei,Jianhui Wu,Jiaxiang Jiang,Yongshi Jia,Fan Mo,Shirong zhang,Xiaodong Liang,Mou Xiaozhou,Jianming Tang +14 more
TL;DR: The results demonstrate that PVT1 serves an oncogenic role and plays an important role in radiosensitivity in malignant NPC via activating the KAT2A acetyltransferase and stabilizing HIF-1α.
References
More filters
Journal ArticleDOI
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay,Isabelle Soerjomataram,Rajesh Dikshit,Sultan Eser,Colin Mathers,Marise Souto Rebelo,Donald Maxwell Parkin,David Forman,Freddie Bray +8 more
TL;DR: The GLOBOCAN series of the International Agency for Research on Cancer (IARC) as mentioned in this paper provides estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012.
Journal ArticleDOI
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
TL;DR: This timely monograph is a distillation of knowledge of hepatitis B, C and D, based on a review of 1000 studies by a small group of scientists, and it is concluded that hepatitis D virus cannot be classified as a human carcinogen.
Book
Cancer Incidence in Five Continents
Freddie Bray,J. Ferlay,Mathieu Laversanne,David H. Brewster,C. Gombe Mbalawa,B. Kohler,Marion Piñeros,Eva Steliarova-Foucher,Rajaraman Swaminathan,Sebastien Antoni,Isabelle Soerjomataram,David Forman +11 more
TL;DR: The aim of this study was to establish a database of histological groups and to provide a level of consistency and quality of data that could be applied in the design of future registries.
Journal ArticleDOI
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R. Aberle,Amanda M. Adams,Christine D. Berg,William C. Black,Jonathan D. Clapp,Richard M. Fagerstrom,Ilana F. Gareen,Constantine Gatsonis,Pamela M. Marcus,JoRean D. Sicks +9 more
TL;DR: Screening with the use of low-dose CT reduces mortality from lung cancer, as compared with the radiography group, and the rate of death from any cause was reduced.